Wegovy on GoodRx: What Coupon Prices Really Mean

A GoodRx screen makes Wegovy pricing look simple, but the number you see there is only one input into what you actually pay at the counter. Explore the full Peptides & GLP-1 library.

Wegovy cost ranks among the most-searched GLP-1 questions in April 2026, and coupon sites are usually the first stop. What follows explains what a GoodRx-style price represents, where the published list price sits, and how insurance, savings cards, and compounding move the final figure.

What GoodRx and coupon sites actually show

Platforms such as GoodRx and SingleCare publish discounted cash prices that vary from pharmacy to pharmacy. Those numbers are real, but they are not a fixed national price — they reflect one pharmacy’s negotiated rate for a cash-paying customer on a given day. Two pharmacies across town can quote different amounts for the same product.

The published list price starting point

Wegovy’s list price is approximately $1,349 per month at U.S. list as of April 2026, per Novo Nordisk’s published pricing. List price is rarely what an insured patient pays; it is the starting point before insurance, rebates, savings cards, and pharmacy negotiation. Out-of-pocket cost then shifts with plan, formulary, prior authorization, and the indication on the prescription.

How insurance changes the counter price

Commercial coverage depends on whether the prescription is written for an FDA-approved indication and on the plan’s formulary and prior-authorization rules. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes; chronic weight-management coverage is more variable, often gated by BMI-based prior authorization, and sometimes excluded entirely. Medicare does not cover weight-management drugs for weight alone as of April 2026, though some cardiovascular indications are covered.

Savings cards and who qualifies

Novo Nordisk publishes a manufacturer savings card that can substantially lower monthly cost for eligible commercially-insured patients.

The eligibility fine print

Eligibility typically excludes Medicare, Medicaid, TRICARE, and other government-funded insurance. Cards carry monthly and annual caps, and both terms and savings amounts change — verify on the manufacturer site at the time of fill rather than trusting a cached figure.

The compounded-pharmacy price lane

During the FDA-declared shortages, 503A compounding pharmacies legally produced semaglutide and tirzepatide. The FDA resolved the semaglutide shortage in late 2024 and tirzepatide in early 2025, narrowing but not eliminating legitimate compounding activity. Compounded products are not identical to the brand and are priced separately through licensed pathways where clinically justified.

Reading a realistic monthly total

With commercial insurance that covers the indication plus the savings card applied, eligible patients may pay as little as $25 per month depending on plan terms and caps. Without indication coverage, cash cost lands closer to list minus any coupon; without insurance at all, it approaches list price. Beneath the price sits biology — variants in FTO and GLP1R shape appetite and glucose handling. The Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights, never predicting drug response, alongside PlexusDx Weight Management Protocols like Semaglutide Injection.

Why coupon prices change so often

The number a coupon platform shows is not fixed, and that surprises people. Pharmacies negotiate rates that move with contracts and local competition, so the same product can be quoted differently across town or from one week to the next. Plan formularies, prior-authorization rules, and the indication on the prescription add further variation on top of the cash-coupon figure. That is why a screenshot from last month is a poor guide to today’s counter price. The practical habit is to confirm the current amount directly with the dispensing pharmacy at the moment you fill, and to check savings-card terms on the manufacturer site at the same time.

It also helps to treat a coupon price and an insurance price as two separate questions. A low cash-coupon quote does not mean your plan will apply it, and a plan that covers the drug may still beat the coupon once a savings card is layered on. Comparing both paths for your specific situation is usually worth the few minutes it takes.

Frequently Asked Questions

Why does GoodRx show different Wegovy prices?

Coupon platforms publish pharmacy-specific cash prices that reflect each pharmacy’s negotiated rate, so quotes vary by location and day. They are legitimate discounts for cash-paying customers but are not a single national price. Always confirm the current amount with the dispensing pharmacy before you fill.

What is the list price of Wegovy?

Approximately $1,349 per month at U.S. list as of April 2026, per Novo Nordisk’s published pricing. That figure precedes insurance, rebates, savings cards, and pharmacy negotiation, so most insured patients pay less. The number you owe at the counter depends heavily on your specific plan and coverage.

Can a savings card and GoodRx be combined?

Generally you use one or the other for a given fill, not both, and manufacturer cards require eligible commercial insurance. Government-insurance patients are typically excluded from manufacturer cards but can still compare coupon prices. Check current terms on the manufacturer site and with the pharmacy at fill time.

Are there lower-cost alternatives to brand Wegovy?

Licensed 503A pharmacies produce compounded semaglutide and tirzepatide at separate price points; these are legally different from the brand and are not generics. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols with published per-protocol pricing. Discuss suitability with a qualified healthcare provider.

Continue learning inside the PlexusDx Education Hub. Browse more Peptides & GLP-1 education.